+218.1%
MRNA vs ALB
-14.4%
+232.6%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | ALB | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -1.4% | -2.1% | -3.0% |
| 7D | -12.1% | -5.8% | -6.4% | -10.4% |
| 30D | -1.3% | -4.5% | +3.2% | +0.3% |
| 3M | +250.9% | -28.1% | +279.0% | +287.2% |
| 6M | +343.0% | -53.2% | +396.2% | +451.2% |
| YTD | +657.4% | -33.3% | +690.8% | +738.5% |
| 1Y | +794.9% | -17.4% | +812.3% | +834.7% |
| 3Y | +218.1% | -14.1% | +232.3% | +199.6% |
| All | +218.1% | -14.4% | +232.6% | +199.6% |
Cumulative growth
Daily Returns
Daily percentage return beside ALB.
Daily Out/Under-Performance
Portfolio return minus ALB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ALB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded ALB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling